Using Propranolol in Traumatic Brain Injury to Reduce Sympathetic Storm Phenomenon

NCT ID: NCT03401515

Last Updated: 2018-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-01

Study Completion Date

2017-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Traumatic Brain Injury (TBI) is one of the leading causes of death. Severe TBT is correlated with an exaggerated stress response due to plasma catecholamine levels known as sympathetic storming. It is also autonomic dysfunction syndrome. This phenomenon is also associated with brain tumors, severe hydrocephalus and subarachnoid hemorrhage. Patients are presented by tachycardia, tachypnea hypertension, diaphoresis, dystonia, hyperthermia, and dilated pupils with elevated levels of plasma catecholamine and blood glucose .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The sympathetic storming events can be triggered by suctioning, repositioning, or environmental stimuli. To differentiate sympathetic storming from similar conditions, symptoms and signs have to occur in TBI patients a minimum of 1 cycle per day for 3 consecutive days (body temperature of 38.5 °C or more, heart rate at least 120 beat / min, systolic blood pressure \> 140 mmHg, respiratory rate \> 20 breaths / min, in presence of dystonia, diaphoresis, agitation and laboratory investigations confirm elevated serum catecholamines. Beta blockers has a cardio protective effect via lowering heart rate, stroke volume and mean arterial blood pressure which limits myocardial O2 consumptions and guards against myocardial infarction. They also have neuron protective effects via reducing cerebral blood flow thus lowering O2 and glucose consumption as cerebral metabolism is reduced. Propranolol a nonselective B receptor antagonists works on β1 receptors in brain, heart, and kidney and β 2 receptors in lungs, liver, skeletal muscles, eye and arterioles.We suppose that using Beta - adrenergic receptor blockers as propranolol blunts the sympathetic storming phenomenon as it is a nonselective β inhibitor and has a lipophilic property which enables it to penetrate blood brain barrier.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Adminstration of propranolol hydrochloride ( 1 MG /ml) 1 mg every 6 hrs .

Group Type ACTIVE_COMPARATOR

Propranolol Hydrochloride 1 MG/ML

Intervention Type DRUG

Propranolol 1 mg every 6 hrs in the first 24 hrs after isolated blunt traumatic brain injury

Control

Adminstration of normal saline 1 mg every 6 hrs

Group Type PLACEBO_COMPARATOR

Normal saline

Intervention Type OTHER

Normal Saline 1 ml every 6 hrs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propranolol Hydrochloride 1 MG/ML

Propranolol 1 mg every 6 hrs in the first 24 hrs after isolated blunt traumatic brain injury

Intervention Type DRUG

Normal saline

Normal Saline 1 ml every 6 hrs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with isolated blunt TBI
* From 18 to 60 years old both sex
* Not in need of mechanical ventilation
* GCS on admission between 9 and 12
* Rotterdam CT score from 2-4.
* Normal Procalcitonin test to exclude infection.

Exclusion Criteria

* Preexisting heart disease
* Myocardial injury
* Craniotomy
* Preexisting cerebral dysfunction
* Spinal cord injury
* Diabetes mellitus
* Severe liver or kidney disease
* Patients with sepsis
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mona Ammar

Lecturer of anesthesia,intensive care and pain management

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1345 AUS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Propranolol for the Treatment of Traumatic Brain Injury
NCT06262061 NOT_YET_RECRUITING EARLY_PHASE1
Early Norepinephrine in Trauma Patients With Hemorrhagic Shock
NCT06977659 ENROLLING_BY_INVITATION PHASE1/PHASE2